Skip to main content
. 2022 Apr 25;13:882678. doi: 10.3389/fphar.2022.882678

FIGURE 7.

FIGURE 7

Pirfenidone level in the heart, liver, spleen, lung and kidney of rats with pulmonary fibrosis after administration to the pulmonary system (4 mgkg−1) (n = 3) (**p < 0.01).

HHS Vulnerability Disclosure